Bertrand Delaisi - Concepedia

Author

Bertrand Delaisi

Also Known As

B Delaisi, B Délaisi, B. Delaisi, BERTRAND DELAISI, Bertrand Delaisi, DELAISI, B., Delaisi, Bertrand, Timothy William Rayner Lee

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Inserm Hôpital Robert-Debré Sorbonne Université Université Paris Cité Assistance Publique – Hôpitaux de Paris

About

Bertrand Delaisi is an author at Inserm specializing in medicine, pediatrics, and pulmonary fibrosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	398
2	Public Health	2	2	71
3	Allergy	2	2	209
4	Health Sciences	1	1	13
5	Allergy Medicine	1	1	90

Bertrand Delaisi

Publications

Citations

H-Index

Page 1

	Year	Citations
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease Pierre‐Régis Burgel, I. Durieu, R. Chiron, American Journal of Respiratory and Critical Care Medicine	2021	227
Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Pierre‐Régis Burgel, À. Munck, I. Durieu, American Journal of Respiratory and Critical Care Medicine	2019	127
Mycobacterial lung disease in cystic fibrosis: a prospective study Brigitte Fauroux, Bertrand Delaisi, Annick Clément, The Pediatric Infectious Disease Journal	1997	121
Influence of Interleukin‐10 on<i>Aspergillus fumigatus</i>Infection in Patients with Cystic Fibrosis Jacques Brouard, Nicola Knauer, Pierre‐Yves Boëlle, The Journal of Infectious Diseases Inflammatory Lung DiseaseMicrobial PathogensImmunodeficienciesImmunologyGenetic Epidemiology	2005	119
Assessment of disease control in allergic rhinitis Pascal Demoly, Moisés A. Calderón, Thomas B. Casale, Clinical and Translational Allergy AsthmaAllergyAllergy MedicineAria Severity ClassificationDisease Control	2013	90
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis D. Hubert, Sylvie Leroy, R. Nové-Josserand, Journal of Cystic Fibrosis PharmacologyAntibiotic AdjuvantAntimicrobial ChemotherapyMedicine	2009	62
Analysis of 40 sporadic or familial neonatal and pediatric cases with severe unexplained respiratory distress: Relationship to <i>SFTPB</i> Mohammed Tredano, Matthias Griese, J. de Blic, American Journal of Medical Genetics Part A NeonatologyRespiratory Distress Syndrome (Pulmonary Critical Care)Pediatric CasesGeneticsGenetic Epidemiology	2003	55
Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosis Cyril Flamant, Alexandra Henrion‐Caude, Pierre-Yves Bo lle, Pharmacogenetics	2004	44
Expression of insulin-like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease K. Chadelat, M. Boule, Sophie Corroyer, European Respiratory Journal AsthmaInflammatory Lung DiseaseLung InflammationInsulin-like Growth FactorsImmunology	1998	38
Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy Julie Bucher, Pierre‐Yves Boëlle, D. Hubert, BMC Infectious Diseases	2015	25

Page 1